Latin America and the Caribbean vs Saudi Arabia: Proportion of the target population who received a 3rd dose of
Latin America and the Caribbean
76.0%
in 2024
Saudi Arabia
96.0%
in 2024
Latin America and the Caribbean rank
17th
Saudi Arabia rank
16th
Proportion of the target population who received a 3rd dose of over time
- Latin America and the Caribbean
- Saudi Arabia
How they compare
Saudi Arabia currently reports 96.0% against 76.0% in Latin America and the Caribbean, a difference of 20.0%.
That makes Saudi Arabia's figure about 1.3 times Latin America and the Caribbean's.
Across all 16 years both countries report, Saudi Arabia has been ahead every year.
Latin America and the Caribbean ranks 17th and Saudi Arabia ranks 16th of 37 groups.
Saudi Arabia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Latin America and the Caribbean | Saudi Arabia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 11.0% | 98.0% | 87.0% | Saudi Arabia |
| 2010s | 71.6% | 97.8% | 26.2% | Saudi Arabia |
| 2020s | 73.4% | 96.6% | 23.2% | Saudi Arabia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received a 3rd dose of, Latin America and the Caribbean or Saudi Arabia?
- Saudi Arabia, at 96.0% against 76.0% in Latin America and the Caribbean as of 2024.
- What is the difference in proportion of the target population who received a 3rd dose of between Latin America and the Caribbean and Saudi Arabia?
- 20.0%, with Saudi Arabia ahead.
- How many years of comparable data are there for Latin America and the Caribbean and Saudi Arabia?
- 16 years are reported by both, from 2009 to 2024.
- How do Latin America and the Caribbean and Saudi Arabia rank globally for proportion of the target population who received a 3rd dose of?
- Latin America and the Caribbean ranks 17th and Saudi Arabia ranks 16th of 37 groups.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.